The prevalence of bleeding disorders among healthy pediatric patients with abnormal preprocedural coagulation studies

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 2, 2008, Pages 135-141

  Shaw, Peter H ^a   Reynolds, Stacy ^a   Gunawardena, Sriya ^a   Krishnamurti, Lakshamanan ^a   Ritchey, Arthur Kim ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Bleeding; Children; Coagulation abnormalities; Lupus anticoagulants; Preoperative screen; Von Willebrand disease

Indexed keywords

LUPUS ANTICOAGULANT; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FAMILY HISTORY; HUMAN; INFANT; NEWBORN; PATIENT REFERRAL; PREDICTIVE VALIDITY; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; SCHOOL CHILD; SCREENING TEST; THROMBOCYTE AGGREGATION; THROMBOPLASTIN TIME; OTORHINOLARYNGOLOGY; PARTIAL THROMBOPLASTIN TIME; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; OTOLARYNGOLOGY; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PROTHROMBIN TIME; REFERRAL AND CONSULTATION; VON WILLEBRAND DISEASE;

EID: 41949093917     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31815d8915     Document Type: Article

References (36)

1. Burk CD, Miller L, Handler SD, et al. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics. 1992;89:691-695.
2. Zwack GC, Derkay CS. The utility of preoperative hemostatic assessment in adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 1997;39:67-76.
3. Kang J, Brodsky L, Danziger I, et al. Coagulation profile as a predictor for post-tonsillectomy and adenoidectomy (T and A) hemorrhage. Int J Pediatr Otorhinolaryngol. 1994;28:157-165.
4. Cariappa R, Wilhite TR, Parvin CA, et al. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. J Pediatr Hematol Oncol. 2003;25:474-479.
5. Rodeghiro F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69:454-459.
6. Werner EJ, Abshire TC, Giroux DS, et al. Relative value of diagnostic studies for von Willebrand's disease. J Pediatr. 1992;121: 35-38.
7. Lusher JM. Clinical an laboratory approach to the patient with bleeding. In: Nathan DG, Orkin SH, Ginsburg D, et al, eds. Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. Philadelphia: W.B. Saunders; 2003:1515-1526.
8. Dean JA, Blanchette VS, Carcao MD, et al. Von Willebrand disease in a pediatric-based population comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding asssay. Thromb Haemost. 2000;84:401-409.
9. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulant/antiphospholipid antibody of the scientfic and standardisation committee of the ISTH. Thromb Haemost. 1995;74:1185-1190.
10. Manning SC, Beste D, McBride T, et al. An assessment of preoperative coagulation screening for tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolaryngol. 1987;13:237-244.
11. Close HL, Kryzer TC, Nowlin JH, et al. Hemostatic assessment of patients before tonsillectomy: a prospective study. Otolaryngol Head Neck Surg. 1994;111:733-738.
12. Smith PS, Orchard PJ, Lekas MD. Predicting bleeding in common ear, nose, and throat procedures: a prospective study. RI Med J. 1990;73:103-106.
13. Bolger WE, Parsons DS, Potempa L. Preoperative hemostatic assessment of the adenotonsillectomy patient. Arch Otolaryngol Head Neck Surg. 1990;103:396-405.
14. Tami TA, Parker GS, Taylor RE. Post-tonsillectomy bleeding: an evaluation of risk factors. Laryngoscope. 1987;97:1307-1311.
15. Handler SD, Miller L, Richmond KH, et al. Post-tonsillectomy hemorrhage: incidence, prevention and management. Laryngoscope. 1986;96:1243-1247.
16. Thomas GK, Arbon RA. Preoperative screening for potential T and A bleeding. Arch Otolaryngol Head Neck Surg. 1970;91: 453-456.
17. Gabriel P, Mazoit X, Ecoffey C. Relationship between clinical history, coagulation tests, and perioperative bleeding during tonsillectomies in pediatrics. J Clin Anesth. 2000;12:288-291.
18. Prim MP, De Diego JI, Jimenez-Yuste N, et al. Analysis of the causes of immediate unanticipated bleeding after pediatric adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2003;67:341-344.
19. De Diego JI, Prim MP, Rodriguez E, et al. Von Willebrand disease as cause of unanticipated bleeding following adeno-tonsillectomy. Int J Pediatr Otorhinolaryngol. 1999;49:185-188.
20. Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993; 123:893-898.
21. Angelini L, Ravelli A, Caporali R, et al. High prevalence of anti-phospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics. 1994;25:500-503.
22. Becton DL, Stine KC. Transient lupus anticoagulant associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome. J Pediatr. 1997;130:998-1000.
23. Casais P, Meschengieser SS, Gennari LC, et al. Morbidity of lupus anticoagulants in children: a single institution experience. Thromb Res. 2004;114:245-249.
24. Galli M, Barbui T. Antiphospholipid syndrome: definition and treatment. Semin Thromb Hemost. 2003;29:195-204.
25. Galli M, Dlott J, Norbis F, et al. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Thromb Haemost. 2000;84:1012-1016.
26. Male C, Lechner K, Eichinger S, et al. Clinical significance of lupus anticoagulants in children. J Pediatr. 1999;134:199-205.
27. Orris DJ, Lewis JH, Spero JA, et al. Blocking coagulation inhibitors in children taking penicillin. J Pediatr. 1980;97:426-429.
28. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood. 2003;101:2089-2093.
29. Miller CH, Haff S, Platt SJ, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost. 2003;1:2191-2197.
30. Budde U, Drewke E, Mainusch K, et al. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost. 2002;28: 173-189.
31. Revel-Vilk S, Schmugge M, Carcao M, et al. Desmopressin (DDAVP) responsiveness in children with von Willebrand disease. J Pediatr Hematol Oncol. 2003;25:874-879.
32. Gill JC, Ottum M, Schwartz B. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type I von Willebrand disease. J Pediatr. 2002;140:595-599.
33. Jimenez-Yuste V, Prim MP, De Diego JI, et al. Otolaryngologic surgery in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg. 2002;128:1365-1368.
34. Allen G, Armfield DR, Bontempo FA, et al. Adenotonsillectomy in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg. 1999;125:547-551.
35. Sukhu K, Beavis J, Keeling DM, et al. The PFA-100s: a screening tool for platelet dysfunction-the Oxford experience. J Thromb Haemost. 2003;1(suppl 1):313. Abstract number OC067.
36. Harrison P, Robinson M, Liesner R, et al. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol. 2002;24:225-232.